Levofloxacino Krka

Levofloxacin, the active ingredient in Levofloxacino Krka, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats a range of bacterial infections, including respiratory, urinary and skin infections, in adult patients. GNH USA supplies Levofloxacino Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is indicated for bacterial infections affecting several organ systems. - Community‑acquired pneumonia: eradicates the causative pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute exacerbation of chronic bronchitis: controls bacterial overgrowth and eases bronchial symptoms. - Uncomplicated urinary tract infection: eliminates uropathogens and resolves urinary symptoms. - Complicated urinary tract infection: provides bactericidal activity against resistant strains in the urinary tract. - Skin and soft‑tissue infections: treats cellulitis, abscesses and other bacterial skin conditions.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness or unsteadiness. - Abdominal pain: cramping or discomfort in the stomach area. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or loss of function, especially in the Achilles. - QT interval prolongation: potential cardiac arrhythmias. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Anaphylaxis: rapid onset of severe allergic reaction. - Peripheral neuropathy: numbness or tingling in extremities. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Before prescribing Levofloxacino Krka, clinicians should consider several safety measures. - Renal function assessment: adjust dose in patients with impaired kidney function. - Hypersensitivity screening: avoid in individuals with known fluoroquinolone allergy. - Elderly caution: monitor for tendon pain and central nervous system effects. - Tendon monitoring: discontinue if sudden tendon pain or swelling occurs. - QT‑prolonging drugs: avoid concurrent use with other agents that lengthen the QT interval. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Levofloxacino Krka can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and INR. - NSAIDs: heightened risk of central nervous system stimulation. - Cyclosporine: increased cyclosporine serum concentrations. - Theophylline: elevated theophylline levels and toxicity risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - Corticosteroids: increased risk of tendon rupture. - Diabetic agents: enhanced hypoglycemic effect. - SSRIs: additive QT‑prolongation potential. - Rifampin: decreased levofloxacin plasma concentrations.